Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/158058
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDefelipe, Lucas A.-
dc.contributor.authorArcon, Juan Pablo-
dc.contributor.authorModenutti, Carlos P.-
dc.contributor.authorMartí, Marcelo A.-
dc.contributor.authorTurjanski,Adrián G.-
dc.contributor.authorBarril Alonso, Xavier-
dc.date.accessioned2020-04-29T14:31:08Z-
dc.date.available2020-04-29T14:31:08Z-
dc.date.issued2018-12-11-
dc.identifier.issn1420-3049-
dc.identifier.urihttp://hdl.handle.net/2445/158058-
dc.description.abstractSimulations of molecular dynamics (MD) are playing an increasingly important role in structure-based drug discovery (SBDD). Here we review the use of MD for proteins in aqueous solvation, organic/aqueous mixed solvents (MDmix) and with small ligands, to the classic SBDD problems: Binding mode and binding free energy predictions. The simulation of proteins in their condensed state reveals solvent structures and preferential interaction sites (hot spots) on the protein surface. The information provided by water and its cosolvents can be used very effectively to understand protein ligand recognition and to improve the predictive capability of well-established methods such as molecular docking. The application of MD simulations to the study of the association of proteins with drug-like compounds is currently only possible for specific cases, as it remains computationally very expensive and labor intensive. MDmix simulations on the other hand, can be used systematically to address some of the common tasks in SBDD. With the advent of new tools and faster computers we expect to see an increase in the application of mixed solvent MD simulations to a plethora of protein targets to identify new drug candidates.-
dc.format.extent14 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherMDPI-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3390/molecules23123269-
dc.relation.ispartofMolecules, 2018, vol. 23, num. 12, p. 3269-
dc.relation.urihttps://doi.org/10.3390/molecules23123269-
dc.rightscc-by (c) Defelipe, Lucas A. et al., 2018-
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es-
dc.sourceArticles publicats en revistes (Farmàcia, Tecnologia Farmacèutica i Fisicoquímica)-
dc.subject.classificationDinàmica molecular-
dc.subject.classificationDisseny de medicaments-
dc.subject.classificationMedicaments peptídics-
dc.subject.otherMolecular dynamics-
dc.subject.otherDrug design-
dc.subject.otherPeptide drugs-
dc.titleSolvents to Fragments to Drugs: MD Applications in Drug Design-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec688207-
dc.date.updated2020-04-29T14:31:09Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.pmid30544890-
Appears in Collections:Articles publicats en revistes (Farmàcia, Tecnologia Farmacèutica i Fisicoquímica)

Files in This Item:
File Description SizeFormat 
688207.pdf884.77 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons